Entrada Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Entrada Therapeutics Inc had 99.28M in cash and cash equivalents.

Entrada Therapeutics Inc reported 71.25M in total liabilities as of the latest reported quarter, including 24.45M in current liabilities and 46.79M in non-current liabilities.

As of the latest reported quarter, Entrada Therapeutics Inc's total assets were 377.38M, consisting of 306.25M in current assets and 71.13M in non-current assets.

Entrada Therapeutics Inc reported 306.13M in total shareholders' equity as of the latest reported quarter.